FFO
PJP icon

Fortitude Family Office’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Fortitude Family Office’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-31
Closed -$3.21K – 2355
2026
Q1 		$3.21K Buy
+31
New +$3.27K ﹤0.01% 1101

Other funds holding PJP

TC
Trilogy Capital Irvine, California $2.58B AUM 22.97% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $145M AUM
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
CIAS
Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return
SAM
Secure Asset Management Troy, Michigan $714M AUM 27.91% 1-Year Est. Return
JWCA
J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return
CI
Cordant Inc Portland, Oregon $278M AUM 23.17% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
BCWM
Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Fortitude Family Office's PJP Position: Q2 2026 in Review

Fortitude Family Office sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2026, closing a stake of 31 shares — an estimated $3.21K sold.

Fortitude Family Office first reported a position in PJP in Q1 2026 and held it in 1 quarter. The position peaked at $3.21K in Q1 2026. 25 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

  • Fortitude Family Office reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2026 after selling out during the quarter.
  • Fortitude Family Office sold 31 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $3.21K.
  • Fortitude Family Office first reported a position in Invesco Pharmaceuticals ETF in Q1 2026 and held it in 1 quarter.
  • Fortitude Family Office's Invesco Pharmaceuticals ETF position peaked at $3.21K in Q1 2026.
  • 25 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.